A renowned Israeli TV journalist who lost his ability to speak clearly because of ALS is returning to the air using ...

Denali Therapeutics' DNL343 fails to slow ALS progression in phase 2/3 trial but shows safety and offers insights for future ...

Beraldi is studying how bacteria in the gut might affect ALS, and how it differs between males and females. His research focuses on whether certain gut bacteria could help protect nerve cells ...

The ALS Association, a patient advocacy group, late on Wednesday said it began working with CMS to investigate "unjust denials" of coverage for the drug by insurance companies, who labeled the ...

EDMONTON — Two Grey Cup champion pivots will be swapping uniform colours in 2025. The Montreal Alouettes and Edmonton Elks announced on Tuesday that they have agreed on a trade that sends McLeod ...

DNL343 and fosigotifator are made to activate the ISR pathway protein eIF2B, but both failed to slow ALS progression in the ...

In May, Raine announced he had been diagnosed with amyotrophic lateral sclerosis (ALS), which causes progressive paralysis, as the brain is no longer able to communicate with muscles.

ALS, the most common of these diseases, is caused by the progressive dysfunction and death of motor neurons, the specialized nerve cells that control voluntary movements. Cardiometabolic diseases are ...

121 ALS patients from the ALS outpatient clinic ... Three items of the ALSFRS_R assess bulbar involvement (speech, salivation, swallowing), which therefore can be rated from 0 (maximum bulbar ...

The brain also sends signals down the vagus nerve to the gut, influencing aspects of the gut environment such as inflammation and digestion, which in turn affect the composition of resident bacteria.

[7,10] Dietary supplements are supposed to affect diverse mechanisms leading to motor neuron death or alleviate symptoms of ALS, often based on theoretical benefits or anecdotal reports.